PULMONARY FUNCTION TESTS ΙΝ ΡΑTIENTS WITH RHEUMATOID ARTHRITIS

Authors

  • Χ. ΑΝΤΩΝΟΓΛΟΥ
  • Ν. ΓΑΛΑΝΟΠΟΥΛΟΣ
  • Ε. ΠΑΠΑΔΟΠΟΥΛΟΥ
  • Σ. ΔΕΥΤΕΡΑΙΟΣ
  • Ι. ΜΑΝΑΒΗΣ
  • Ν. ΓΚΟΤΣΗΣ

Abstract

Το define lung involvement, obstructive or restrictιve pattern, in rheumatoid arthritis patients we studied the lung function in 66 patients (49 women, 58y±10) and in a control group of 44 healthy subjects (32 women, 59y±7) matched for age, sex and smoking status. 

The evaluation of the forced expiratory volume in one second (FEV1), the forced vital capacity (FVC), the vital capacity (VC), the FEV1/FVC, the forced expiratory flow between 25% and 75% of the vital capacity (FEF25-75), the maximal expiratory flow at the 50% of the vital capacity (Vmax50) and the flow - volume loop in the two populations revealed lower values than predicted ίin 18 patients (27%, 5 obstructiνe pattern, 4 restrictive pattern and 9 small airways) and in 4 healthy subjects (9%), p< 0,01. The patients in this group were older than the patients with normal values, were treated with methotrexate for longer period (p<0,01) and had more frequently positiνe findings for Sjogren syndrome in salivary gland biopsy (p<0,01). Νο significant differences were noted for rheumatoid factor seropositivity, presence of anemia, concentration of CRP, radiographic bone erosions and abnormal chest radiography, between the two groups of the patients. The disease duration, the age of the onset, the corticosteroid therapy (percentage, duration, total and current daily dose) and the methotrexate therapy (percentage, current weekly dose) were not significantly different between the two groups of the patients.

References

Schwarz Μ.: Pulmonary manifestations of the collagen νascular diseases in Fishman's Pulmonary diseases and disorders, 3 ed, McGrow Hill, 1:1122-26, USA, 1998

Harris Ε.: Pulmonary disease in Rheumatoid arthritis in Textbook of Rheumatology, 4th ed, Saunders, 1: 898, USA, 1993

Radoux V., Menard Η., Begin R., et al: Airways disease in rheumatoid arthritis patients, Arthritis Rheum 3: 249-56, 1987

Sassoon C., McAlpine S., Tashkin D., et al: Small airways function in non smokers with reumatoid arthritis, Arthritis Rheum 11: 1228-26, 1984

Banks J., Banks C., Cheong Β., et al: An epidemiological and clinical inνestigation of pulmonary function and respiratory symptoms in patients with Rheumatoid arthritis, Q J Med, 85: 795-806, 1992

Fulmer J.: Διάμεση πνευμονοπάθεια στην Παθολογία Stein, Αθήνα, εκδ. Πασχαλίδη , II1: 197-211, 1997

Σπηλιώτης Τρ., Διάμεση πνευμονοπάθεια στα ρευματικά νοσήματα, Ελληνική Ρευματολογία, 6: 9-18, 1994

Arnett Α., Edworthy S., Bloch D., et al: The ARA 1987 reνised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31: 315-24, 1988

Standarized lung function testing, Eur. Respir. J, 6: 5-52, 1993

Κnudson RJ, Statin RC, Lebowitz MD, Burtow Β.: The maximal expiratory flow-νolume curve, Am Reν Respir Dis 113: 587-600, 1976

Crapo R.: Pulmonary function testing, Ν Engl J Med, 331:25-30, 1994

Loke J., Έλεγχος πνευμονικής λειτουργίας στην Παθολογία Stein, Αθήνα, εκδ Πασχαλίδη, ΙΙΙ: 70-78, 1997

Larsen Α.,: How to apply Larsen score in eνaluation radiography of RA in long term studies? S Rheumatol, 22: 1974, 1995

Chisholm D., Mason D.: Labial saliνary gland biopsy in Sjogren disease, J Clinic Pathol 21: 656-60, 1968

Morrison S., Mody G., Benatar S., Meyers Ο. : The lungs in rheumatoid arthritis-a clinical, radiographic and pulmonary function stydy, S Afr Med J, 7: 829-33, 1996

Perez Τ., Remy-Jardin Μ., Cortet Β.: Airways involvement in reumatoid arthritis: clinical, functional and HRCT findings, Am J Respir Crit Care Med, 157: 1658-65, 1998

Barrear Ρ., Laan R., vanRiel Ρ., et al: Methotrexate related pulmonary complications in rheumatoid artritis, Ann Rheum Dis 53: 434-39, 1994

Schnabel Α., Daldoff Κ., Bauerfeind S., et al: Sustained Cough in Methotrexate Therapy for Rheumatoid Arthritis, Clinical rheumatology, 15: 277-282, 1996

Hilliquin Ρ., Renoux Μ., Perrot S., et al: Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis, British Journal of rheumatology, 35: 441-445, 1996

Roschmann R., Rothenberg R.: Pulmonary fibrosis in rheumatoid arthrits, Semin Athr Rheurn 16: 175-185, 1987

Andonopoulos Α., Constandopoulos S., Drosos Α. , Moutsopoulos Η.: Pulmonary function of non smoking patients with rheumatoid arthritis in the presence and absence of secondary Sjogren syndrome, Respiration, 4: 252-8, 1988

Papiris S., Maniati Μ., Constandopoulos S., et al: Lung involvement in primary Sjogren syndrome is mainly related to the small airway diseases, Ann Rheum Dis, 58: 61-64, 1999

Vitali C., Bombardieri S., Moutsopoulos Η., et al: Preliminary criteria for the classification of Sjogren syndrome, Arthritis Rheum, 36: 340-7, 1993